Avalere Health Global Limited

POWER SEARCH PRICING

SOLUTIONS

avalere health global limited Company Information

Company Number

04096110

Next Accounts

Dec 2025

Directors

Jonathan Koch

Brendan Ferretti

View All

Shareholders

fishawack medical communications ltd

Group Structure

View All

Industry

Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

Registered Address

the featherstone building, 66 city road, london, EC1Y 2AL

Website

www.fishawack.com

avalere health global limited Estimated Valuation

£57.1m

Pomanda estimates the enterprise value of AVALERE HEALTH GLOBAL LIMITED at £57.1m based on Net Assets of £24.9m and 2.3x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Avalere Health Global Limited is a live company located in london, EC1Y 2AL with a Companies House number of 04096110. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in October 2000, it's largest shareholder is fishawack medical communications ltd with a 100% stake. Avalere Health Global Limited is a mature, large sized company, Pomanda has estimated its turnover at £26m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Avalere Health Global Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

5 Strong

0 Regular

6 Weak

Size

annual sales of £26m, make it larger than the average company (£1.7m)

Growth

3 year (CAGR) sales growth of 15%, show it is growing at a faster rate (8.6%)

EXPORT

Avalere Health Global Limited's latest turnover from March 2024 is £26 million and the company has net assets of £24.9 million. According to their latest financial statements, Avalere Health Global Limited has 325 employees and maintains cash reserves of £297.7 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	26,017,772	34,605,845	22,519,246	16,891,025	12,055,359	10,459,335	8,555,170	6,641,806	6,119,251	7,219,805	8,643,752	6,543,258	4,701,566	4,633,666	5,466,643
Other Income Or Grants
Cost Of Sales	24,650,709	24,311,959	18,749,472	13,104,663	9,321,932	7,134,192	5,451,509	4,752,767	4,238,408	4,809,957	4,597,172	3,744,244	2,467,855	2,330,482	3,887,900
Gross Profit	1,367,063	10,293,886	3,769,774	3,786,362	2,733,427	3,325,143	3,103,661	1,889,039	1,880,843	2,409,848	4,046,580	2,799,014	2,233,711	2,303,184	1,578,743
Admin Expenses	5,844,436	5,004,949	4,340,845	2,776,582	2,416,761	2,390,895	1,850,254	1,922,880	1,916,774	1,621,024	1,716,822	1,285,776	1,034,926	1,224,455	1,496,468
Operating Profit	-4,477,373	5,288,937	-571,071	1,009,780	316,666	934,248	1,253,407	-33,841	-35,931	788,824	2,329,758	1,513,238	1,198,785	1,078,729	82,275
Interest Payable		380,115	259,389	129,634					26	101	225	2,084		2,938
Interest Receivable	2,335,572	1,971,080	1,376,970	1,383,968				620,050	233,136	221,494	634	407	417	561	1,875
Pre-Tax Profit	-2,141,801	6,879,902	546,510	2,264,114	316,666	934,248	1,253,407	586,209	197,179	1,010,217	2,330,167	1,511,561	1,199,202	1,076,352	84,150
Tax	1,373,785	-1,333,802	-6,648	-52,654	205,434	15,593	-122,084	5,597	15,674	17,850	-414,631	-7,719	-129,190	-111,601	-23,562
Profit After Tax	-768,016	5,546,100	539,862	2,211,460	522,100	949,841	1,131,323	591,806	212,853	1,028,067	1,915,536	1,503,842	1,070,012	964,751	60,588
Dividends Paid						1,021,522								500,000
Retained Profit	-768,016	5,546,100	539,862	2,211,460	522,100	-71,681	1,131,323	591,806	212,853	1,028,067	1,915,536	1,503,842	1,070,012	464,751	60,588
Employee Costs	20,970,583	20,415,630	15,955,995	11,243,535	8,073,222	6,567,890	4,901,226	3,978,172	3,295,674	3,170,976	2,913,562	2,557,112	1,922,695	2,127,560	1,196,359
Number Of Employees	325	335	295	224	179	143	117	91	70	66	76	64	48	49	32
EBITDA*	-4,299,798	5,529,045	-297,721	1,263,807	534,709	1,077,172	1,415,470	71,694	87,011	863,624	2,411,070	1,570,234	1,238,608	1,113,322	106,142

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets	212,789	259,950	466,088	537,057	550,397	488,759	333,873	208,495	239,453	243,449	234,223	140,993	86,118	78,751	59,792
Intangible Assets
Investments & Other
Debtors (Due After 1 year)								18,483,534	5,497,735	5,067,516	7,657,289	4,792,573	2,858,917	1,335,554
Total Fixed Assets	212,789	259,950	466,088	537,057	550,397	488,759	333,873	18,692,029	5,737,188	5,310,965	7,891,512	4,933,566	2,945,035	1,414,305	59,792
Stock & work in progress
Trade Debtors	1,308,207	1,699,341	1,104,553	502,244	507,339	597,539	574,370	818,348	766,477	1,068,822	1,317,745	812,411	676,331	629,704	1,440,551
Group Debtors	26,806,854	38,259,677	41,241,051	35,441,674	31,411,209	29,221,318	21,007,572	453,715	8,165,067	5,490,740
Misc Debtors	4,273,013	2,472,200	1,290,158	1,201,343	678,899	867,452	640,748	496,630	746,039	701,163	1,377,702	670,466	477,931	429,973
Cash	297,714	1,698,711	1,421,501	569,090	360,191	2,674,155	2,135,623	626,231	1,085,978	656,999	389,513	423,010	163,714	268,094	750,123
misc current assets
total current assets	32,685,788	44,129,929	45,057,263	37,714,351	32,957,638	33,360,464	24,358,313	2,394,924	10,763,561	7,917,724	3,084,960	1,905,887	1,317,976	1,327,771	2,190,674
total assets	32,898,577	44,389,879	45,523,351	38,251,408	33,508,035	33,849,223	24,692,186	21,086,953	16,500,749	13,228,689	10,976,472	6,839,453	4,263,011	2,742,076	2,250,466
Bank overdraft
Bank loan
Trade Creditors	84,037	314,873	139,561	79,780	455,720	1,352,187	1,154,849	320,354	308,972	263,410	306,406	267,886	185,186	126,055	1,595,841
Group/Directors Accounts	2,979,266	13,175,256	22,269,928	16,550,642	13,924,354	13,973,210	14,159,772	12,958,072	8,820,253	5,999,705
other short term finances
hp & lease commitments														1,650	4,950
other current liabilities	4,941,052	5,237,512	2,997,724	2,044,710	1,763,145	1,681,110	1,438,050	992,189	1,141,395	927,382	1,492,959	1,104,479	1,003,214	967,698
total current liabilities	8,004,355	18,727,641	25,407,213	18,675,132	16,143,219	17,006,507	16,752,671	14,270,615	10,270,620	7,190,497	1,799,365	1,372,365	1,188,400	1,095,403	1,600,791
loans											4,124,583	2,317,834	1,429,371	1,071,539
hp & lease commitments
Accruals and Deferred Income								8,146
other liabilities															545,292
provisions									13,743	34,659		12,266	12,094	12,000	6,000
total long term liabilities								8,146	13,743	34,659	4,124,583	2,330,100	1,441,465	1,083,539	551,292
total liabilities	8,004,355	18,727,641	25,407,213	18,675,132	16,143,219	17,006,507	16,752,671	14,278,761	10,284,363	7,225,156	5,923,948	3,702,465	2,629,865	2,178,942	2,152,083
net assets	24,894,222	25,662,238	20,116,138	19,576,276	17,364,816	16,842,716	7,939,515	6,808,192	6,216,386	6,003,533	5,052,524	3,136,988	1,633,146	563,134	98,383
total shareholders funds	24,894,222	25,662,238	20,116,138	19,576,276	17,364,816	16,842,716	7,939,515	6,808,192	6,216,386	6,003,533	5,052,524	3,136,988	1,633,146	563,134	98,383

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-4,477,373	5,288,937	-571,071	1,009,780	316,666	934,248	1,253,407	-33,841	-35,931	788,824	2,329,758	1,513,238	1,198,785	1,078,729	82,275
Depreciation	177,575	240,108	273,350	254,027	218,043	142,924	162,063	105,535	122,942	74,800	81,312	56,996	39,823	34,593	23,867
Amortisation
Tax	1,373,785	-1,333,802	-6,648	-52,654	205,434	15,593	-122,084	5,597	15,674	17,850	-414,631	-7,719	-129,190	-111,601	-23,562
Stock
Debtors	-10,043,144	-1,204,544	6,490,501	4,547,814	1,911,138	8,463,619	1,970,463	5,076,909	2,847,077	1,975,505	4,077,286	2,262,271	1,617,948	954,680	1,440,551
Creditors	-230,836	175,312	59,781	-375,940	-896,467	197,338	834,495	11,382	45,562	-42,996	38,520	82,700	59,131	-1,469,786	1,595,841
Accruals and Deferred Income	-296,460	2,239,788	953,014	281,565	82,035	243,060	437,715	-141,060	214,013	-565,577	388,480	101,265	35,516	967,698
Deferred Taxes & Provisions								-13,743	-20,916	34,659	-12,266	172	94	6,000	6,000
Cash flow from operations	6,589,835	7,814,887	-5,782,075	-3,431,036	-1,985,427	-6,930,456	595,133	-5,143,039	-2,505,733	-1,667,945	-1,666,113	-515,619	-413,789	-449,047	243,870
Investing Activities
capital expenditure	-130,414	-33,970	-202,381	-240,687	-279,681	-297,810	-287,441	-74,577	-118,946	-84,026	-174,542	-111,871	-47,190	-53,552	-83,659
Change in Investments
cash flow from investments	-130,414	-33,970	-202,381	-240,687	-279,681	-297,810	-287,441	-74,577	-118,946	-84,026	-174,542	-111,871	-47,190	-53,552	-83,659
Financing Activities
Bank loans
Group/Directors Accounts	-10,195,990	-9,094,672	5,719,286	2,626,288	-48,856	-186,562	1,201,700	4,137,819	2,820,548	5,999,705
Other Short Term Loans
Long term loans										-4,124,583	1,806,749	888,463	357,832	1,071,539
Hire Purchase and Lease Commitments													-1,650	-3,300	4,950
other long term liabilities														-545,292	545,292
share issue						8,974,882				-77,058					37,795
interest	2,335,572	1,590,965	1,117,581	1,254,334				620,050	233,110	221,393	409	-1,677	417	-2,377	1,875
cash flow from financing	-7,860,418	-7,503,707	6,836,867	3,880,622	-48,856	8,788,320	1,201,700	4,757,869	3,053,658	2,019,457	1,807,158	886,786	356,599	520,570	589,912
cash and cash equivalents
cash	-1,400,997	277,210	852,411	208,899	-2,313,964	538,532	1,509,392	-459,747	428,979	267,486	-33,497	259,296	-104,380	-482,029	750,123
overdraft
change in cash	-1,400,997	277,210	852,411	208,899	-2,313,964	538,532	1,509,392	-459,747	428,979	267,486	-33,497	259,296	-104,380	-482,029	750,123

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for avalere health global limited. Get real-time insights into avalere health global limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for avalere health global limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in EC1Y area or any other competitors across 12 key performance metrics.

AVALERE HEALTH GLOBAL LIMITED group structure

Avalere Health Global Limited has no subsidiary companies.

Ultimate parent company

AVALERE HEALTH TOPCO LIMITED

12357729

FISHAWACK MEDICAL COMMUNICATIONS LIMITED

08279590

2 parents

AVALERE HEALTH GLOBAL LIMITED

04096110

AVALERE HEALTH GLOBAL LIMITED Shareholders

fishawack medical communications ltd

100%

Avalere Health Global Limited currently has 5 directors. The longest serving directors include Mr Jonathan Koch (Nov 2021) and Mr Brendan Ferretti (Jun 2022).

officer	country	age	start	end	role
Mr Jonathan Koch	United Kingdom	50 years	Nov 2021	-	Director
Mr Brendan Ferretti	England	45 years	Jun 2022	-	Director
Mr John Gransee	United Kingdom	59 years	Jan 2024	-	Director
Mrs Harriet Shurville	United Kingdom	38 years	Jan 2025	-	Director
Amar Urhekar	United Kingdom	50 years	Jan 2025	-	Director

P&L

March 2024

turnover

26m

-25%

operating profit

-4.5m

-185%

gross margin

5.3%

-82.34%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2024

net assets

24.9m

-0.03%

total assets

32.9m

-0.26%

cash

297.7k

-0.82%

net assets

Total assets minus all liabilities

Similar Companies

prime medica limited

als life sciences limited

md manchester limited

1.5

involve visual collaboration ltd

priority space holdings limited

company number

04096110

Type

Private limited with Share Capital

industry

74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

incorporation date

October 2000

ultimate parent company

AVALERE HEALTH TOPCO LIMITED

previous names

fishawack communications limited (August 2024)

broomco (2370) limited (February 2001)

address

the featherstone building, 66 city road, london, EC1Y 2AL

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 16 charges/mortgages relating to avalere health global limited. Currently there are 2 open charges and 14 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for AVALERE HEALTH GLOBAL LIMITED. This can take several minutes, an email will notify you when this has completed.

avalere health global limited Company Information

avalere health global limited Estimated Valuation

avalere health global limited Estimated Valuation

avalere health global limited Estimated Valuation

Avalere Health Global Limited Overview

Avalere Health Global Limited Health Check

AVALERE HEALTH GLOBAL LIMITED financials

avalere health global limited Credit Report and Business Information

Avalere Health Global Limited Competitor Analysis

avalere health global limited Ownership

avalere health global limited directors

avalere health global limited company details

avalere health global limited Charges & Mortgages

avalere health global limited Capital Raised & Share Issues BETA

avalere health global limited Companies House Filings - See Documents